6 Results for "

sequestosome

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "sequestosome" in MCE Product Catalog:

  • Targets Recommended:
7
7 Publications Verification
Cat. No.: HY-112904
CAS No.: 2375193-43-2
Purity:  99.08%
Target:  

p62 Autophagy

Research Areas:  

Cancer

XRK3F2 is a p62 (sequestosome-1) ZZ domain inhibitor that has specificity for the p62-ZZ domain over other p62 signaling domains. XRK3F2 blocks TNFα effects and upregulation in bone marrow stromal cells, and induces multiple myeloma cell apoptosis. XRK3F2 can be used for the research of multiple myeloma bone disease, acute myeloid leukemia, and multiple myeloma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P80518
Synonyms: ORCA, OSIL, SQSTM1, sequestosome-1, EBI3-associated protein of 60 kDa, Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa, Ubiquitin-binding protein p62, EBIAP, p60, p62

Host:  

Mouse

Application:  

IHC-P, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-161746
CAS No.: 2941386-44-1
Target:  

AUTOTACs Autophagy

Research Areas:  

Neurological Disease

Anle138b-F105 is an autophagy-targeting chimera (AUTOTAC) that targets p62/Sequestosome-1/SQSTM1. Anle138b-F105 binds to the ZZ domain of p62, induces conformational activation, self-oligomerization, interaction with LC3, and formation of autophagosomes. Anle138b-F105 induces autophagic flux of ubiquitin-conjugated aggregated proteins, leading to their lysosomal degradation. Anle138b-F105 is applicable for the research of neurodegenerative proteinopathies .
loading...
    loading...
Cat. No.: HY-152100
CAS No.: 1370032-20-4
Purity:  98.69%
Target:  

Autophagy

Research Areas:  

Cancer

CUR5g is a potent autophagy inhibitor. CUR5g selectively inhibits autophagosome degradation in cancer cells by blocking autophagosome-lysosome fusion. CUR5g blocks the recruitment of STX17 to autophagosomes via a UVRAG-dependent mechanism, resulting in the inability of autophagosomes to fuse with lysosomes. CUR5g improves the anticancer effect of Cisplatin (HY-17394) against A549 cells both in vitro and in vivo .
loading...
    loading...
Cat. No.: HY-112904A
CAS No.: 2375193-42-1
Target:  

p62

Research Areas:  

Cancer

XRK3F2 free base is a p62 (sequestosome-1) ZZ domain inhibitor that has specificity for the p62-ZZ domain over other p62 signaling domains. XRK3F2 free base blocks TNFα effects and upregulation in bone marrow stromal cells, and induces multiple myeloma cell apoptosis. XRK3F2 free base can be used for the research of multiple myeloma bone disease, acute myeloid leukemia, and multiple myeloma .
loading...
    loading...
Cat. No.: HY-P87714
Synonyms: ORCA, OSIL, SQSTM1, sequestosome-1, EBI3-associated protein of 60 kDa, Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa, Ubiquitin-binding protein p62, EBIAP, p60, p62

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...